Mobile

Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder

Mise à jour : Il y a 4 ans
Référence : NCT01054222

Femme et Homme

  • | Pays :
  • Portugal
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

This is an open-label extension study intended for subjects who have previously completed study A0221045 (fesoterodine in elderly OAB patients) and who have been recommended by the investigator as being suitable for the extended use of Fesoterodine. Data from this study will extend the evaluation of efficacy, tolerability and safety of Fesoterodine in older subjects from Portugal.

Critère d'inclusion

  • Urinary Bladder, Overactive

Liens